The malarial protein, called VAR2CSA, could provide the tool for carrying anti-cancer drugs to tumors and thus could help stop cancer.
Bristol-Myers Squibb and Five Prime Therapeutics To Develop Drugs For Cancer
California-based Five Prime Therapeutics could receive up to $1.75 billion if they succeed in developing and getting approval for both cancer drugs and for other illnesses.
California-based Five Prime Therapeutics could receive up to $1.75 billion if they succeed in developing and getting approval for both cancer drugs and for other illnesses.
"This specific type of developmental protein -- oncofetal chondroitin sulfate -- is expressed in the placenta, and is also expressed in lung cancer and in melanoma," Tran said. Malaria uses VAR2CSA to embed itself in the placenta -- hiding itself from the immune system -- by binding to oncofetal chondroitin sulfate.
In laboratory experiments, researchers found that if they used the malarial protein, VAR2CSA, and attached an anti-cancer drug to it, it would bind with the oncofetal protein in the cancer, delivering the drug to the tumor.
New Method of Cancer Treatment Will be Available in India Within 6-9 Months
One can be treated as an outpatient with little or no side effects and at a much lower cost compared to other existing forms of treatment.
One can be treated as an outpatient with little or no side effects and at a much lower cost compared to other existing forms of treatment.
Source-IANS
Cyprus University Researchers Design Early Cancer Screening Device
The capsule is designed to detect micro-cancers in the small intestine, thus enabling early detection and removal of cancerous cells.
The capsule is designed to detect micro-cancers in the small intestine, thus enabling early detection and removal of cancerous cells.
Delay in Gp�s Referral to Specialists Claims 2400 Cancer Deaths Every Year in the UK
Cancer patients must visit a specialist within two weeks of seeing a General Physician with suspected cancer symptoms but most do not regularly use the pathway.
Cancer patients must visit a specialist within two weeks of seeing a General Physician with suspected cancer symptoms but most do not regularly use the pathway.
